top of page

Insights and News Curated for Life Science Experts by Life Science Experts....

Go back to...
JMG Logo transparent.png
Executive Spotlights

Lilly to acquire DICE Therapeutics for approximately $2.4B

Indianapolis and South San Francisco, CA, June 20, 2023 (PRNewswire) -- Lilly announced the acquisition of DICE Therapeutics, a biopharmaceutical company known for its groundbreaking DELSCAPE technology platform. The strategic move aims to bolster Lilly's efforts in developing novel oral therapeutic candidates to address the urgent medical needs of patients suffering from chronic immunological conditions, marking a significant advancement in the field.


Read full article here.

Recent Posts

See All

Comments


Life Science Headlines

© 2024 by Jacobs Management Group, Inc.

​

Privacy Policy

​

bottom of page